Oaktree-backed NL Holding buys ProCrea, Archimed, Imer

Francesca Veronesi
16 February 2018

Tweet
Facebook
LinkedIn
Google plus
Send to

Oaktree Capital Management-backed German healthcare technology group NL Holding has acquired competitors ProCrea Group, Archimed and the Instituto de Medicina Reproductiva (Imer) to create a pan-European group.

NL Holding was backed by Oaktree in Q4 2017 and announced at the time its objective of expanding internationally.

The MBO of 2017, valued at around €200m, saw Oaktree acquire a minority stake alongside management and private investors, a source close to the deal confirmed.

The previous year, management and private investors injected €60-80m in NL Holding, Unquote understands.

Founded in 2015 by Martin Würtele and originally named Next LL Holding, NL Holding is a group of healthcare technology companies focusing on reproductive medicine, pneumology, allergology and clinical immunology. Its services are currently available in the Czech Republic and Germany. The company is registered in Germany and headquartered in Aystetten.

NL Holding aims to build a European network of clinics that focus on reproductive medicine. More acquisitions are planned for 2018, and an additional €45-60m could be invested in the company later on in the year, a spokesperson for NL Holding disclosed.

Company
ProCrea, operating in the Italian-speaking region of Switzerland as well as northern Italy, is a diagnostics service and provides vitro fertilisation treatments. The company is based in Lugano.

Archimed is a diagnostic center specialising in genetics, with facilities in northern Italy. It offers laboratory and diagnostic services for 600 healthcare facilities in Italy.

Imer provides diagnostics services and in vitro fertilisation treatments. Based in Spain, the company also manages egg-donation centres that work closely with facilities for assisted reproduction in Italy. The company is headquartered in Valencia and also operates centres in Denia and Barcelona.

People
NL Holding – Martin Würtele (founder); Miroslaw Herden (CEO); Josef Brož (head of advisory board).
Oaktree Capital Management – Hermann Dambach, Andreas Krämer, (managing directors); Heiko Keppler (senior vice-president).